Prestige Brands Prepares To Weather Retailers' Inventory Storm
This article was originally published in The Pink Sheet
Executive Summary
The firm's sales of BC, Goody's, Monistat and other consumer health care brands grow 4.3% in North America and 17.8% internationally in its latest quarter. CEO Ron Lombardi says Prestige Brands expects lower volume orders from retailers during the current quarter and early 2017.
You may also be interested in...
DenTek Deal Expands Prestige Brands’ Oral Care Portfolio, OTC Focus
While overall oral care sales grow 2.4% in the 52-week period through Oct. 3, sales of the sub-category of floss picks, dental guards, interdental brushes, disposable picks, dental wax, floss threaders, dental picks and tongue cleaners grew 9%. DenTek is first in floss pick sales and second in interdental brush sales.
Prestige Brands Visits Doctors To Cure Slumping Monistat Sales
The firm in the second half of 2015 plans six initiatives to influence health care professionals on recommending Monistat for patients, CEO Matthew Mannelly says. Sales of Monistat have slid since a previous owner of the brand stopped marketing to health care professionals.
In Brief: Prestige Buys Insight, Quarterly Earnings For MJN And Colgate, Bio-Recovery Warned On Claims
Prestige acquires Insight Pharmaceuticals; Product relaunches boost Novartis’ consumer sales; Colgate’s N.A. sales inch up; Mead Johnson sales up 7%; and Bio-Recovery makes drug claims.